Verition Fund Management’s ACELYRIN SLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-27,480
Closed -$86.3K 3675
2024
Q4
$86.3K Sell
27,480
-82,635
-75% -$400K ﹤0.01% 3094
2024
Q3
$543K Buy
110,115
+39,100
+55% +$202K ﹤0.01% 2269
2024
Q2
$313K Buy
71,015
+60,166
+555% +$282K ﹤0.01% 2323
2024
Q1
$73.2K Buy
+10,849
New +$82.4K ﹤0.01% 2611

Other funds holding SLRN

Verition Fund Management's SLRN Position: Q1 2025 in Review

Verition Fund Management sold out of ACELYRIN (SLRN) in Q1 2025, closing a stake of 27,480 shares — an estimated $86.3K sold.

Verition Fund Management first reported a position in SLRN in Q1 2024 and held it in 4 quarters. The position peaked at $543K in Q3 2024. 105 funds tracked by Wall St. Rank hold SLRN as of Q1 2025.

  • Verition Fund Management reported no remaining ACELYRIN position as of Q1 2025 after selling out during the quarter.
  • Verition Fund Management sold 27,480 ACELYRIN shares in Q1 2025, an estimated $86.3K.
  • Verition Fund Management first reported a position in ACELYRIN in Q1 2024 and held it in 4 quarters.
  • Verition Fund Management's ACELYRIN position peaked at $543K in Q3 2024.
  • 105 funds tracked by Wall St. Rank held ACELYRIN as of Q1 2025.

Based on Verition Fund Management's 13F filing for Q1 2025, filed 15 May 2025.